Conmed Corp (CNMD) Reports In-Line Q2 EPS; Lowers FY14 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $49.25 -0.38%
Revenue Growth %: -0.5%
Financial Fact:
Total operating expenses: 87.36M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Revenue Growth %: -0.5%
Financial Fact:
Total operating expenses: 87.36M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Conmed Corp (NASDAQ: CNMD) reported Q2 EPS of $0.47, in-line with the analyst estimate of $0.47. Revenue for the quarter came in at $188.2 million versus the consensus estimate of $190.62 million.
Conmed Corp sees FY2014 EPS of $1.85-$1.95, versus prior guidance of $1.9-$2 and the consensus of $1.94. Conmed Corp sees FY2014 revenue of $735-745 million, versus prior guidance of $770-780 million and the consensus of $766.27 million.
For earnings history and earnings-related data on Conmed Corp (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- Boston Beer Co. (SAM) Tops Q3 EPS by 15c; offers guidance
- Investing.com’s stocks of the week
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
